Nunzia Pharmaceutical Company (NUNZ)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 21, 2026
9,900%
Market Cap 43.45K
Revenue (ttm) n/a
Net Income (ttm) -96.99M
Shares Out 434.51M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 10,798
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0001
Beta -3.28
RSI 33.71
Earnings Date n/a

About NUNZ

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Lon... [Read more]

Sector Healthcare
Founded 1986
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol NUNZ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.